This inventor holds 3 USPTO granted patents, plus 4 CIPO patents and 4 EPO patents. Top assignee: Selexis S.a.. Active years: 2012-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2020
Title: Innovations of Duc-Quang Nguyen
Introduction
Duc-Quang Nguyen is a notable inventor based in Saint Prex, Switzerland. He has made significant contributions to the field of gene transfer and expression in mammalian cells. With a total of three patents to his name, Nguyen's work focuses on enhancing protein production through innovative methods.
Latest Patents
Nguyen's latest patents include a groundbreaking invention titled "High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of MAR sequences." This invention relates to purified and isolated DNA sequences that have protein production increasing activity. Specifically, it utilizes matrix attachment regions (MARs) to enhance protein production in eukaryotic cells. The patent also discloses a method for identifying active regions, particularly MAR nucleotide sequences, and introduces a new multiple transfection method using these characterized active MAR sequences.
Career Highlights
Duc-Quang Nguyen is currently associated with Selexis S.A., where he continues to advance his research and innovations. His work has been instrumental in the development of techniques that improve gene transfer efficiency, which is crucial for various applications in biotechnology and medicine.
Collaborations
Nguyen collaborates with esteemed colleagues such as Pierre Alain Girod and Philipp Bucher. Their combined expertise contributes to the success of their projects and the advancement of their research.
Conclusion
Duc-Quang Nguyen's contributions to gene transfer technology exemplify the impact of innovative thinking in biotechnology. His patents reflect a commitment to enhancing protein production, which holds promise for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile